Health X Platform share price
NSE: HEALTHXBSE: 533259Healthcare ServicesSmall Cap
Formerly Sastasundar Ventures
Last close ₹266.80down ₹2.05 (0.76%)BSE ₹261.90
Share price at the NSE close on 23 Oct 2026. Previous close ₹268.85.
52-week range of traded prices to 23 Oct 2026
₹252.50Low, 30 Mar 2026₹363.00High, 13 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹849 Cr1,526th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- −3.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- −9.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,88571.6% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 7 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹447 Crup 19.55%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹1.99 CrQuarter to Mar 2026: −₹13 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 0.4%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 8 of the 10 years shown
The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹159 Cr, differs from its quarters added, ₹165 Cr.
| ₹ crore | Sep 2024Filed 10 Jan | Dec 2024Filed 3 Apr | Mar 2025Filed 30 May | Jun 2025Filed 12 Aug | Sep 2025Filed 13 Nov | Dec 2025Filed 6 Feb | Mar 2026Filed 30 May | Jun 2026Filed 7 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 274 | 281 | 286 | 298 | 301 | 346 | 374 | 447 |
| Net profit | −155 | −38 | 18 | 27 | −15 | 0 | −13 | 2 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −56.6% | −13.4% | 6.1% | 8.9% | −5.1% | 0.1% | −3.5% | 0.4% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Healthcare NetworkHealthcare Network, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹1,283 Crup 17.93%97.3%
- Financial ServicesFinancial Services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹13 Crdown 41.61%1.0%
- OthersOthers, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹23 Cr1.7%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history. Not shown, P/E: loss, last twelve months. Not shown, EV/EBITDA: operating loss, last twelve months. Dividend yield is not shown: no dividend in the years on record. Its history crosses a change of basis in the accounts in the year to Mar 2018: days before it are of the company before the change.PE ratio and valuation history
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 40% of 1,925 trading days since Nov 2018.
LowestHighest
Its median1.4Industry median1.6
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +6.0% | – | – | 0.0% |
| 3 years | +5.2% | – | – | 0.0% |
| 5 years | +17.1% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Peers and competitors
Healthcare Service Provider, 36 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Health X Platform in market cap.
Health X Platform is not on the chart: it has no P/E today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Nephrocare Health ServicesNEPHROPLUS | 5,998 | – | 5.4 | – | – | – | – | – | 0.00% |
 Krsnaa DiagnosticsKRSNAA | 1,617 | 16.6 | 1.6 | 8.2 | +10.2% | +21.5% | 10.5% | 8.0% | 0.40% |
 Suraksha DiagnosticSURAKSHA | 1,559 | 43.6 | 6.4 | 15.0 | +23.3% | +8.1% | 15.7% | 24.0% | 0.17% |
 3B Blackbio Dx3BBLACKBIO | 1,145 | 20.6 | 3.5 | 19.6 | +54.3% | +13.2% | 18.7% | 14.1% | 0.37% |
 One Global Service ProviderONEGLOBAL | 703 | 9.5 | 5.0 | 7.0 | +161.6% | +178.3% | 69.4% | 69.2% | 0.28% |
 Gaudium IVF and Women HealthGAUDIUMIVF | 670 | – | 4.4 | – | – | – | – | – | 0.00% |
| Credent Connect N CareCREDENT | 572 | – | – | – | – | – | – | – | 0.00% |
 Chandan HealthcareCHANDAN | 562 | – | – | – | – | – | – | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
| Ex-date | Type | Per share |
|---|---|---|
| 23 Jul 2012 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
| 25 Jul 2011 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
Aug 2026
Health X Platform share price by year
Each calendar year to 2025.Health X Platform share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 295.10 | −6.9% | 328.35 | 208.23 |
| 2024 | 316.85 | −22.8% | 451.70 | 281.95 |
| 2023 | 410.20 | +45.9% | 477.05 | 220.55 |
| 2022 | 281.10 | −42.1% | 560.90 | 256.00 |
| 2021 | 485.60 | +276.7% | 562.00 | 113.15 |
| 2020 | 128.90 | +79.2% | 145.10 | 42.45 |
| 2019 | 71.95 | −24.3% | 122.25 | 65.95 |
| 2018 | 95.00 | −25.8% | 130.15 | 79.00 |
| 2017 | 128.00 | +72.7% | 149.90 | 70.90 |
| 2016 | 74.10 | −15.7% | 93.10 | 44.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 269.30 | 293.90 | 260.00 | 266.80 | 265.65 | 7,885 | 71.6% |
| 22 Oct 2026 | 272.55 | 274.90 | 267.10 | 268.85 | 269.43 | 1,014 | 92.7% |
| 21 Oct 2026 | 277.60 | 287.50 | 267.95 | 271.10 | 273.77 | 5,780 | 54.2% |
| 19 Oct 2026 | 283.00 | 290.90 | 278.75 | 279.80 | 280.76 | 2,512 | 80.8% |
| 16 Oct 2026 | 289.15 | 292.15 | 282.20 | 283.75 | 285.19 | 3,106 | 75.6% |
| 15 Oct 2026 | 289.90 | 299.40 | 282.05 | 283.50 | 291.28 | 5,592 | 63.1% |
| 14 Oct 2026 | 284.00 | 291.00 | 281.05 | 286.10 | 286.77 | 1,704 | 98.8% |
| 13 Oct 2026 | 281.35 | 292.90 | 280.00 | 283.00 | 284.77 | 6,550 | 60.8% |
| 12 Oct 2026 | 292.70 | 297.05 | 281.65 | 284.00 | 286.30 | 6,669 | 54.6% |
| 9 Oct 2026 | 303.00 | 303.00 | 286.00 | 291.25 | 291.22 | 2,562 | 64.8% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Health X Platform Limited
- NSE symbol
- HEALTHX
- BSE code
- 533259
- ISIN
- INE019J01013
- Industry
- Healthcare Services
- Listed
- Oct 2010
- Face value
- ₹10
- Former symbols
- SASTASUNDR, MICROSEC
- CIN
- L65993WB1989PLC047002
- Corporate identity number, the registrar of companies' code for it